Bioethics News

Parkinson disease incalculable effects in Europe

Parkinson disease is the second most common neurodegenerative disorder. Its annual cost in Europe in 2010 was around 14,000 million Euros, and its effect on the quality of life of patients and their families is incalculable (The Lancet 383; 1107-1109, 2014).

La entrada Parkinson disease incalculable effects in Europe aparece primero en Observatorio de Bioética, UCV.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.